TargetMol

RO 23-6152

Product Code:
 
TAR-T28571
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T28571-5mg5mg£1,091.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28571-50mg50mg£2,143.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28571-100mg100mg£2,801.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
RO 23-6152, a new calcium antagonist, can inhibit platelet aggregation in vitro associated with occlusive coronary thrombus formation.
CAS:
108383-96-6
Formula:
C26H29ClN2O4S
Molecular Weight:
501.04
Purity:
0.98
SMILES:
Cl.COc1ccc(cc1)[C@@H]1Sc2c(ccc3ccccc23)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O

References

1. Sordahl LA, Rex KA, Benedict CR. In vivo inhibition of platelet aggregation and occlusive coronary thrombus formation by a new calcium antagonist (R023-6152). J Cardiovasc Pharmacol. 1991 Oct;18(4):504-10. PubMed PMID: 1724526. 2. Medh JD, Rex KA, Benedict CR, Sordahl LA. In vitro and in vivo effects of R023-6152 on heart mitochondrial calcium and energy metabolism. J Cardiovasc Pharmacol. 1991 Oct;18(4):473-7. PubMed PMID: 1724522. 3. Folkers HB, van Zwienen JC, Boer P, Kleinbloesem CH, Geyskes GG. Hemodynamic effects of Ro 23-6152 in patients with essential hypertension. Eur J Clin Pharmacol. 1991;41(4):307-11. PubMed PMID: 1804644.